Market Cap 4.45B
Revenue (ttm) 8.55M
Net Income (ttm) -182.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,138.25%
Debt to Equity Ratio 0.00
Volume 868,100
Avg Vol 939,746
Day's Range N/A - N/A
Shares Out 25.01M
Stochastic %K 74%
Beta 2.82
Analysts Strong Sell
Price Target $314.93

Company Profile

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-ty...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 300 8460
Address:
99 High Street, 30th Floor, Boston, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:47 AM
$PRAX: The last close at $186.42 indicates a strong position above the 30-day moving average (MA30) of $147.37 and the 50-day moving average (MA50) of $106.97, suggesting bullish momentum. The RSI at 50.24 reflects a neutral stance, indicating potential for movement in either direction. Given the 60-day high of $206.71 and low of $37.19, the current price is closer to the high, which supports a bullish bias. Suggested trade plan: - Entry: $188.00 (above last close to confirm upward momentum) - Stop: $175.00 (below recent support) - Target 1: $200.00 (psychological resistance) - Target 2: $206.71 (60D high) Monitor for any shifts in RSI or price action that may indicate a change in trend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$PRAX is currently trading at $178.08, with an RSI of 51.98 indicating a neutral momentum. The stock is above its 30-day moving average (MA30) of 142.97 and its 50-day moving average (MA50) of 104.18, suggesting a bullish trend in the short to medium term. The recent high of $206.71 within the last 60 days indicates potential resistance, while the low of $37.19 provides a clear support level. Given the current price position and the neutral RSI, a cautious bullish stance is warranted. Suggested entry is at $180.00, with a stop loss set at $170.00 to limit downside risk. Target 1 is set at $200.00, aligning with the recent high, and Target 2 is set at $206.00, just below the 60D high, to capture potential gains while managing risk. Overall, the trade plan is to capitalize on upward momentum while being mindful of resistance levels. https://privateprofiteers.com
0 · Reply
FE123
FE123 Nov. 14 at 6:36 PM
$TENX $PRAX $CDTX Bring those Profits to $TENX!!
0 · Reply
R84877P
R84877P Nov. 14 at 4:05 PM
$PRAX Up $OTH Up
0 · Reply
FE123
FE123 Nov. 14 at 3:51 PM
$PRAX $CDTX Bring those Profits to Steve Cohens $TENX only 4.5 Million Shares! 106% Ownership!! Phase3 $TENX Next t $200
0 · Reply
Okadarlan
Okadarlan Nov. 14 at 3:45 PM
$PRAX same old shit, pump a few articles, and price targets, raise it by like 7 % or 11 bucks, retail sheepishly buys and monday this opens at 170.
2 · Reply
FE123
FE123 Nov. 14 at 2:01 PM
$PRAX $CDTX Huge Winners for Steve Cohen! Now he loves $TENX!! Squeeeeze!!
0 · Reply
Okadarlan
Okadarlan Nov. 14 at 11:44 AM
$PRAX it's over.
0 · Reply
FE123
FE123 Nov. 14 at 10:47 AM
$PRAX $CDTX $TENX Steve Cohen!
0 · Reply
FE123
FE123 Nov. 14 at 10:17 AM
$CDTX $PRAX Steve Cohen loaded up Now he is loading up $TENX for $200
0 · Reply
Latest News on PRAX
What's fueling PRAX stock's jaw-dropping 235% surge on Thursday?

Oct 16, 2025, 12:02 PM EDT - 4 weeks ago

What's fueling PRAX stock's jaw-dropping 235% surge on Thursday?


Praxis Precision Medicines to Host PRAX-628 Program Update

Mar 25, 2024, 4:01 PM EDT - 1 year ago

Praxis Precision Medicines to Host PRAX-628 Program Update


PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:47 AM
$PRAX: The last close at $186.42 indicates a strong position above the 30-day moving average (MA30) of $147.37 and the 50-day moving average (MA50) of $106.97, suggesting bullish momentum. The RSI at 50.24 reflects a neutral stance, indicating potential for movement in either direction. Given the 60-day high of $206.71 and low of $37.19, the current price is closer to the high, which supports a bullish bias. Suggested trade plan: - Entry: $188.00 (above last close to confirm upward momentum) - Stop: $175.00 (below recent support) - Target 1: $200.00 (psychological resistance) - Target 2: $206.71 (60D high) Monitor for any shifts in RSI or price action that may indicate a change in trend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$PRAX is currently trading at $178.08, with an RSI of 51.98 indicating a neutral momentum. The stock is above its 30-day moving average (MA30) of 142.97 and its 50-day moving average (MA50) of 104.18, suggesting a bullish trend in the short to medium term. The recent high of $206.71 within the last 60 days indicates potential resistance, while the low of $37.19 provides a clear support level. Given the current price position and the neutral RSI, a cautious bullish stance is warranted. Suggested entry is at $180.00, with a stop loss set at $170.00 to limit downside risk. Target 1 is set at $200.00, aligning with the recent high, and Target 2 is set at $206.00, just below the 60D high, to capture potential gains while managing risk. Overall, the trade plan is to capitalize on upward momentum while being mindful of resistance levels. https://privateprofiteers.com
0 · Reply
FE123
FE123 Nov. 14 at 6:36 PM
$TENX $PRAX $CDTX Bring those Profits to $TENX!!
0 · Reply
R84877P
R84877P Nov. 14 at 4:05 PM
$PRAX Up $OTH Up
0 · Reply
FE123
FE123 Nov. 14 at 3:51 PM
$PRAX $CDTX Bring those Profits to Steve Cohens $TENX only 4.5 Million Shares! 106% Ownership!! Phase3 $TENX Next t $200
0 · Reply
Okadarlan
Okadarlan Nov. 14 at 3:45 PM
$PRAX same old shit, pump a few articles, and price targets, raise it by like 7 % or 11 bucks, retail sheepishly buys and monday this opens at 170.
2 · Reply
FE123
FE123 Nov. 14 at 2:01 PM
$PRAX $CDTX Huge Winners for Steve Cohen! Now he loves $TENX!! Squeeeeze!!
0 · Reply
Okadarlan
Okadarlan Nov. 14 at 11:44 AM
$PRAX it's over.
0 · Reply
FE123
FE123 Nov. 14 at 10:47 AM
$PRAX $CDTX $TENX Steve Cohen!
0 · Reply
FE123
FE123 Nov. 14 at 10:17 AM
$CDTX $PRAX Steve Cohen loaded up Now he is loading up $TENX for $200
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:42 AM
$PRAX is currently trading at $178.08, with an RSI of 51.98 indicating a neutral momentum. The stock is above its 30-day moving average (MA30) of 142.97 and its 50-day moving average (MA50) of 104.18, suggesting a bullish trend in the short to medium term. The recent high of $206.71 within the last 60 days indicates potential resistance, while the low of $37.19 provides a clear support level. Given the current price position and the neutral RSI, a cautious bullish stance is warranted. Suggested entry is at $180.00, with a stop loss set at $170.00 to limit downside risk. Target 1 is set at $200.00, aligning with the recent high, and Target 2 is set at $206.00, just below the 60D high, to capture potential gains while managing risk. Overall, the trade plan is to capitalize on upward momentum while being mindful of resistance levels. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 12:22 PM
HC Wainwright & Co. has updated their rating for Praxis Precision Medicine ( $PRAX ) to Buy with a price target of 258.
0 · Reply
FE123
FE123 Nov. 13 at 10:25 AM
$TENX Phase3 Company! Only 4.5 Million Shares!! 106% Ownership!!!! Steve Cohen wants Another $PRAX!!
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:49 AM
$PRAX is currently trading at $183.56, with an RSI of 49.6 indicating a neutral momentum. The price is significantly above the 30-day moving average (MA30) of 134.52 and the 50-day moving average (MA50) of 98.8, suggesting a bullish trend in the medium term. The 60-day high of 206.71 presents a potential resistance level, while the low of 37.19 indicates a strong support base. Given the current price near the midpoint of the recent range and the neutral RSI, the directional bias leans slightly bullish. A suggested entry point could be around $185, with a stop loss set at $170 to manage risk. Target 1 can be set at $200, aligning with the 60D high, and Target 2 at $206.71, providing a potential for further upside. This trade plan capitalizes on the bullish trend indicated by the moving averages while managing risk effectively. https://privateprofiteers.com
0 · Reply
ChaseDeluca
ChaseDeluca Nov. 12 at 11:57 PM
TRUG setting up for a super squeeze, 0 shares to short, 30%+ shorted, low RSI on weekly and daily, recent MASSIVE news, no dilution risk here, cash on hand, undervalued. EVERYTHING TO BE THE NEXT BIG. RUNNER $PRAX $MTC $RANI $CMBM
0 · Reply
CoolCatTrades
CoolCatTrades Nov. 12 at 3:03 PM
Made a killing on this guys call, Gave @MomentumZeus a FOLLOW . Insane trader. He called CMCT couple days ago and it just ran 100%+ Wathcing for runs on $RANI $MAMK $PRAX $TERN ---
0 · Reply
R84877P
R84877P Nov. 12 at 2:44 PM
$PRAX Price Target $270
0 · Reply
Okadarlan
Okadarlan Nov. 12 at 2:35 PM
$PRAX top is in.
0 · Reply
FE123
FE123 Nov. 12 at 1:50 PM
$TENX $SPRB $PRAX $TENX next over $100 with Positive Phase3 results!!
0 · Reply
Okadarlan
Okadarlan Nov. 12 at 12:52 PM
$PRAX Before Hours Volume: 21
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Nov. 12 at 5:17 AM
$PRAX I might have to add more puts, it's so fucking obvious that FDA requires more studies. If you cannot see that from what has happened you should not be in biotech. Take my advice use the pazdur pump to get out.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:24 AM
$PRAX is currently trading at $183.56, with an RSI of 49.6 indicating a neutral momentum. The price is significantly above the 30-day moving average (MA30) of 134.52 and the 50-day moving average (MA50) of 98.8, suggesting a bullish trend in the medium term. The 60-day high of 206.71 presents a potential resistance level, while the low of 37.19 indicates a strong support base. Given the current price near the midpoint of the recent range and the neutral RSI, the directional bias leans slightly bullish. A suggested entry point could be around $185, with a stop loss set at $170 to manage risk. Target 1 can be set at $200, aligning with the 60D high, and Target 2 at $206.71, providing a potential for further upside. This trade plan capitalizes on the bullish trend indicated by the moving averages while managing risk effectively. https://privateprofiteers.com
0 · Reply